Robert Mccarthy III in Columbia, Maryland

Medical School: Rush Medical College Of Rush University
Graduation Year: 1991
The Primary Medical Specialty for Robert Mccarthy III is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 33
PAC (PECOS ID)#: 5395934137
NPI #: 1760477327
NPI Created On: 09/20/2005
NPI Last Updated Listed as: 06/08/2010
Primary Taxonomy Code: 207RC0000X
License Number:
D0046300
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• CareFirst BlueChoice, Inc.
• Humana
• Group Hospitalization and Medical Services Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
4. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
5. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
6. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
7. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
8. New patient office or other outpatient visit, typically 30 minutes
9. New patient office or other outpatient visit, typically 45 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Established patient office or other outpatient, visit typically 40 minutes
13. Initial hospital inpatient care, typically 70 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Technetium tc-99m sestamibi, diagnostic, per study dose
16. Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)